Gary M. Reedy was CEO of the American Cancer Society and the American Cancer Society Cancer Action Network from 2015 to 2021. His leadership emphasized disciplined focus on maximizing the Society’s support of progress against cancer, optimizing volunteer and customer experiences, expanding stewardship and engagement, leading innovation, and advancing health equity. Under his leadership, the organization set a precedent-shattering goal to reduce cancer mortality by an additional 40% by 2035 and created the Blueprint for Cancer Control in the 21st Century to help the nation reach that goal. Previously, Reedy served as worldwide vice president, government affairs and policy at Johnson & Johnson, president of Ortho Biotech, and in senior leadership roles at SmithKline Beecham and Centocor. He holds appointments to the Board of Directors of the Center for Global Health Innovation, Board of Councilors for The Carter Center, Georgia Tech Advisory Board, Dean’s Council at Emory University’s Rollins School of Public Health, Advisory Board for Emory University’s Center for Ethics, and MMM Tech Advisory Council.